CD82 is a marker to isolate β cell precursors from human iPS cells and plays a role for the maturation of β cells
Abstract Generation of pancreatic β cells from pluripotent stem cells is a key technology to develop cell therapy for insulin-dependent diabetes and considerable efforts have been made to produce β cells. However, due to multiple and lengthy differentiation steps, production of β cells is often unst...
Guardado en:
Autores principales: | Ami Watanabe, Anna Tanaka, Chizuko Koga, Masahito Matsumoto, Yasushi Okazaki, Tatsuya Kin, Atsushi Miyajima |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0045ce09fa434bfe9dd473e76af13f0e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Synergistic gene editing in human iPS cells via cell cycle and DNA repair modulation
por: Thomas L. Maurissen, et al.
Publicado: (2020) -
Single-cell RNA-sequencing of differentiating iPS cells reveals dynamic genetic effects on gene expression
por: Anna S. E. Cuomo, et al.
Publicado: (2020) -
Impaired NEPHRIN localization in kidney organoids derived from nephrotic patient iPS cells
por: Tomoko Ohmori, et al.
Publicado: (2021) -
Generation of Col2a1-EGFP iPS cells for monitoring chondrogenic differentiation.
por: Taku Saito, et al.
Publicado: (2013) -
The therapeutic potential of multiclonal tumoricidal T cells derived from tumor infiltrating lymphocyte-1derived iPS cells
por: Takeshi Ito, et al.
Publicado: (2021)